Gladstone in the News

The Gladstone Institutes is gratified to receive media attention from around the globe. Check out the highlights of recent press coverage of Gladstone scientists and research. For other news, please be sure to follow us on Facebook and Twitter.

Reducing Brain Activity Aids Memory After Cognitive Decline
May 14, 2012

A study led by a Johns Hopkins neuroscientist and published in the May 10 issue of the journal Neuronsuggests a potential new therapeutic approach for improving memory and interrupting disease progression in patients with a form of cognitive impairment that often leads to full-blown Alzheimer’s disease.

Super cells: The Gladstone Institutes Gala
May 13, 2012

Rare is the soiree that makes science sizzle. But that was the fact last week during the Gladstone Institutes Gala at the Four Seasons Hotel, where 450 guests were greeted by lab-coat-wearing waiters bearing test tubes filled with cocktails.

Reducing Brain Activity Improves Memory After Cognitive Decline
May 10, 2012

Research in mouse models of familial AD conducted at the Gladstone Institutes of San Francisco has identified mechanisms of the brain that contribute to abnormal excitatory brain activity, as reported in a paper published in the April 27 issue of the journal Cell.

FDA panel recommends approval of drug to prevent HIV infection
May 10, 2012

For the first time in the 30-year battle against the HIV epidemic, a panel of experts has recommended that the Food and Drug Administration approve a drug to give to healthy people to protect against the infection.

HIV prevention pill Truvada backed by US experts
May 10, 2012

A panel of US health experts has for the first time backed a drug to prevent HIV infection in healthy people.

Gladstone's Dr. Robert M. Grant advises FDA on drug to prevent HIV infection risk
May 10, 2012

History was made Thursday evening as an FDA panel recommended approval of a drug that could prevent the spread of HIV, the virus that causes AIDS -- a disease that has killed 30 million people around the world.

Development of Nuclear Re-programming Technology for Generating Induced Pluripotent Stem Cells
May 10, 2012

Gladstone Institutes' Senior Investigator Dr. Shinya Yamanaka is profiled for his pioneering work in stem cell technology.

F.D.A. Advisory Panel Backs Preventive Use of H.I.V. Drug
May 10, 2012

SILVER SPRING, Md. — A drug already used to treat H.I.V.infection should also be approved to prevent it, an advisory panel to the Food and Drug Administration said on Thursday. The recommendation is the first time that government advisers have advocated giving antiviral medicine to healthy people who might be exposed through sexual activity to the virus that causes AIDS.

Unlocking doors and unraveling mysteries
May 7, 2012

The first annual gala for the Gladstone Institutes raises awareness of its mission “to unravel the basics of biology in order to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease.”

Studies Tie Abnormal Protein Buildup to Dementia
May 5, 2012

Gladstone investigator Li Gan is quoted in this article about recent studies indicating that abnormal protein deposits in brain cells may contribute to frontotemporal degeneration.